Henatinib
Product Specifications
CAS Number
1239269-51-2
Target
PDGFR|||c-Kit|||Others|||VEGFR
Related Pathways
Others|||Tyrosine Kinase/Adaptors|||Angiogenesis
Bioactivity
Henatinib is an orally active small molecule multi-kinase inhibitor with broad antitumour effects. henatinib inhibits the activity of VEGFR-2 (IC50: 0.6 nM), c-kit (IC50: 3.3 nM), PDGFR (IC50: 41.5 nM) . henatinib significantly inhibits VEGFR-2 phosphorylation and its downstream signalling pathways in human umbilical vein endothelial cells (HUVECs) . Henatinib significantly inhibited VEGFR-2 phosphorylation and its downstream signaling pathway in human umbilical vein endothelial cells (HUVECs) .
Smiles
C(=C\1/C=2C(NC1=O)=CC=C(F)C2)\C3=C(C)C4=C(N3)CCCN(C[C@@H](CN5CCOCC5)O)C4=O
Molecular Formula
C25H29FN4O4
Molecular Weight
468.52
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS962010-01 0.02 mg (E-Coli)
Recombinant Mouse Keratin, type I cytoskeletal 24 (Krt24)
Ask
View Details